Breast cancer is the most common cancer worldwide. The occurrence of breast cancer is
associated with many risk factors, including genetic and hereditary predisposition. Breast …

Osteoporosis is a global public health problem, with fractures contributing to significant
morbidity and mortality. Although postmenopausal osteoporosis is most common, up to 30 …

In 2018, the predicted number of new breast cancers in 28 European Union (EU) countries
was 404 920, with estimated age-adjusted annual incidence of breast cancer of 144.9/100 …

Background The recurrence score based on the 21-gene breast cancer assay predicts
chemotherapy benefit if it is high and a low risk of recurrence in the absence of …

ABSTRACT The 15th St. Gallen International Breast Cancer Conference 2017 in Vienna,
Austria reviewed substantial new evidence on loco-regional and systemic therapies for early …

Background The use of adjuvant chemotherapy in patients with breast cancer may be
guided by clinicopathological factors and a score based on a 21-gene assay to determine …

In 2012, the estimated age-adjusted annual incidence of breast cancer in 40 European
countries was 94.2/100 000 and the mortality 23.1/100 000 [1]. The incidence increased …

ABSTRACT The 14th St Gallen International Breast Cancer Conference (2015) reviewed
substantial new evidence on locoregional and systemic therapies for early breast cancer …

Biomarkers play an essential role in the management of patients with invasive breast
cancer. For selecting patients likely to respond to endocrine therapy, both oestrogen …

Background Growth of hormone-receptor–positive breast cancer is dependent on cyclin-
dependent kinases 4 and 6 (CDK4 and CDK6), which promote progression from the G1 …